|
|
San Francisco, California June 11, 2008
ARX (Algorithmic Research), a leading provider of digital signature (standard electronic signature) solutions, has successfully implemented a CoSign® digital signature solution at the Muscular Dystrophy Association (MDA), the world's largest non-governmental sponsor of research, seeking the causes of and effective treatments for muscular dystrophy and related diseases.
Like many organizations, MDA wanted to reduce their paper-based workflow comprised of memos, purchase orders, and executive-level authorizations. Management within the organization decided that as a way to accelerate the time consuming business approval processes, the association's dependence on paper needed to be reduced. In order to eliminate the need to reintroduce paper into the workflow for signing purposes, MDA required a digital signature solution. As it is a standards-based solution that is deployable out-of-the-box, MDA decided to implement the CoSign digital signature solution.
"We were in search of a digital signature solution that would allow us to expedite inner-office communications and workflows, without demanding an expensive or time-consuming set up," said David Wagar, IT Project Manager, MDA. "CoSign allows us to integrate digital signatures with whatever manual or automated workflow and document management system that we implement in the future."
CoSign's implementation will allow MDA to reduce their work processes from days to minutes, as office documentation will no longer require physical routing for signing purposes. In addition, the reduction in paper alleviates the resources MDA needs to concentrate on document archival.
"CoSign not only provides strong digital signatures as required by MDA, but also includes the application of hand-written, graphical signatures and out-of-the-box integration with PDF and Microsoft® Office, which were all requirements for MDA," said Rodd Schlerf, Life Sciences and Healthcare Market Manager, ARX. |
|
About the Muscular Dystrophy Association
The Muscular Dystrophy Association is a national voluntary health agency dedicated to conquering more than 40 diseases that affect a million Americans of all ages.
|
|
About CoSign Digital Signatures
ARX (Algorithmic Research) is a global provider of cost-efficient digital signature solutions for industries such as AEC, life sciences, healthcare, government, energy, and manufacturing. ARX CoSign® is the market leading digital signature solution. CoSign digital signatures fully automate signature-dependent processes affordably and compliantly, allowing organizations to go paperless and save time and money. Compatible with major document types including Word, Excel®, PDF, PDF/A, and IBM Forms, CoSign signatures are globally verifiable without requiring proprietary validation software. CoSign is also centrally managed by your organization for reliable control over signature privileges. Learn more about the CoSign digital signature solution.
|
|
About ARX - The Digital Signature Company
ARX (Algorithmic Research) is a global provider of cost-efficient digital signature solutions for industries such as life sciences, healthcare, government, engineering, and energy. ARX engineers and scientists have more than 20 years of experience in security and standard digital signature applications. ARX helps businesses secure, streamline, and scale their processes and transactions with the proper controls required by legislation, regulation, and industry best practices. Learn more about us.
|
|
###
CoSign is a registered trademark of Algorithmic Research, Ltd. All other trade names and trademarks are the property of their respective holders.
|
|
|
|
|
|
|
|
